Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, tolerability, and pharmacokinetics of GDC-0973 in combination with GDC-0068 in patients with locally advanced or metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• GDC-0068
• GDC-0973

Snippet

Sponsor: Genentech, Inc. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2016-03-28